![](/img/cover-not-exists.png)
Implications of the ESVEM trial for use of antiarrhythmic drugs that prolong cardiac repolarization
Jay W. MasonVolume:
72
Year:
1993
Language:
english
Pages:
1
DOI:
10.1016/0002-9149(93)90964-e
File:
PDF, 300 KB
english, 1993